Master of Regulatory Affairs

MRA Curriculum

The goal of the MRA curriculum is to provide a broad understanding of the FDA-regulated product lifecycle. The core courses focus on research and development, clinical research, FDA submissions and product registrations, manufacturing, labeling, advertising and post-approval maintenance activities. Course instructors bring expertise from academic medical centers, private industry, and the FDA. This prepares students to pursue careers in clinical research, regulatory or quality assurance sectors.

The MRA curriculum is designed for working professionals. The courses are scheduled in the evenings, typically at 4:00PM or later.

The MRA degree requires 10 credit units including coursework and a capstone. Students may choose to complete the degree in 2 or 3 years. Students may request an extension beyond 3 years for extenuating circumstances; a program fee may apply.


Degree Requirements

Core Courses

All students take 5 core courses.

  • REG 5100 Introduction to Clinical and Translational Research (1 c.u.)
  • REG 6100 Fundamentals of FDA Regulation (1 c.u.)
  • REG 6120 Introduction to Drug Development (1 c.u.)
  • REG 6190 Research Ethics (1 c.u.)
  • REG 6150 Post-Approval Maintenance of Drugs, Devices, and Biologics (1 c.u.) 
    • * Can be subsituted for another course listed in "Areas of Focus" in consultation with your academic advisor.

Areas of Focus/ Elective Courses

Choose 3 courses here to further specialize your training with an area of focus or elective courses. Additional electives may be approved at request in consultation with your academic advisor and program director.

  • REG 6110 Clinical Trial Management: Offers a particular focus on GCP-compliant management of clinical trials. *Can be subsituted for REG 6150.
  • REG 6160 Quality Management: Offers a particular focus on GLP and GMP-compliant management of product development and manufacturing. *Can be subsituted for REG 6150.
  • REG 6180 Introduction to Drug Development
  • REG 6220 New Trends in Medicine and Vaccine REG 6240 Applied Regulatory Processes of Vaccines and Biologics 
  • REG 6250 Manufacturing Novel Therapies & Imaging Agents
  • REG 6260 Patent Law for Drug Development
  • REG 6270 Drug Development Decision Criteria

See the full list of Pre-approved electives here. 

*Note: Not all courses are taught in every term and may alternate in different years.

Capstone

  • REG 6400 Capstone I (1 c.u.)
  • REG 6410 Capstone II (1 c.u.)

Study Plans

Two-Year Study Plan

All students are required to complete the 4 core courses and Capstone I in year 1. MRA is a total of 10 course units (C.U.s).

Year 1 - Fall

  • REG 5100 Intro Clinical Research
  • REG 6120 Intro Drug Development

Year 1 - Spring

  • REG 6400 Capstone I
  • REG 6190 Research Ethics

Year 1 - Summer

  • REG 6100 Fundamentals of FDA Regulations
  • Area of Focus / Elective Course 1

Year 2 - Fall

  • Area of Focus / Elective Course 2
  • Area of Focus / Elective Course 3

Year 2 - Spring

  • REG 6410 Capstone II
  • REG 6150 Post-Approval Maintenance of Drugs, Devices, and Biologics 

Three-Year Study Plan

All students are required to complete the 4 core courses and Capstone I in year 1. MRA is a total of 10 course units (C.U.s). 

Year 1 - Fall

  • REG 5100 Intro Clinical Research
  • REG 6120 Intro Drug Development

Year 1 - Spring

  • REG 6400 Capstone I
  • REG 6190 Research Ethics

Year 1 - Summer: REG 6100 Fundamentals of FDA Regulation

Year 2 - Fall: Area of Focus / Elective 1

Year 2 - Spring: REG 6150 Post-Approval Maintenance of Drugs, Devices, and Biologics 

Year 2 - Summer: Area of Focus / Elective 2

Year 3 - Fall: Area of Focus / Elective 3

Year 3 - Spring: REG 6410 Capstone II


 

Regulatory Affairs Courses

For descriptions of REG courses, please see the University of Pennsylvania catalogue. 

Visit the ITMAT Education Courses page for an up-to-date listing of which courses are offered each semester.

In addition to the courses listed on this page, MRA students may take additional REG courses as electives or courses outside the department. Some courses may be offered on-site at Penn rather than online. 

  • REG 6180 Introduction to Vaccine Development 
  • REG 6210 Cell & Gene Therapy 
  • REG 6240 Applied Regulatory Processes of Vaccines and Biologics
  • REG 6250 Manufacturing Novel Therapies & Imaging Agents 
  • REG 6260 Patent Law for Drug Development
  • LAWM 5360 Fundamentals of US Legal Research 

 

Classes that may not be offered online: 

  • REG 6220 New Trends in Medicine & Vaccine Discovery
  • MTR 6200 Commercializing Translational Therapeutics
  • HCMG 8990 Management & Economics of the Pharma, Biotech & Medical Device Industries
  • PUBH 5020 Introduction to Epidemiology
  • LAW 5220 Compliance and Corporate Governance 
  • LAW 5290 Navigating the Regulatory State
  • LAW 5300 Intro to Health Law & Policy 
  • LAW 9200 Pharmaceutical Regulation & Enforcement
  • BMIN 5010 Intro to Biomedical Informatics
  • BMIN 5020 Databases in Biomedical Research
  • BIOE 5520 Bioethics & the Law
  • BIOE 5750 Health Policy

Please review Penn's catalogue for course descriptions. 

Accreditation

The University of Pennsylvania is accredited, but there is no separate accreditation for regulatory affairs programs.